The National Methadone Conference

American Association for the Treatment of Opioid Dependence
Washington, D.C. ~ April 13-16, 2003


Pre Conference Session 8:30 AM – 5:45 PM
April 12, 2003

Sharon Dow, MS
Joint Commission
Washington, DC
Joanne Page, MSW
Council On Accreditation
New York, NY
Walter Ginter
NAMA
Westport, CT
J. Thomas Payte, MD
Drug Dependence Associates
San Antonio, TX
Bettye Harrison, MSW, LISW
CARF Accreditation
Tucson, AZ
C. Todd Rosendale, MA
CSAT/Division of Pharmacologic Therapies
Rockville, MD
Herman Joseph, PhD
New York State Office of
Alcoholism and Substance Abuse Services
New York, NY
Joycelyn Sue Woods, MA
NAMA
New York, NY

NAMA would also like to thank our Faces of Advocacy: Alice Diorio, New England Alliance of Methadone Advocates; Robert Lubran, CSAT; Ira Marion, AECOM; Carmen Pearman, The MAG of Indiana; Valerie Robinson, DANYA; Rick Samson, FAVOR; Paul Samuels, Legal Action.

It is NAMA’s view that everyone who believes in methadone treatment is a potential methadone advocate. We encourage all supporters of methadone treatment, patient and non-patient, to become Certified Methadone Advocates (CMA) so that all energies directed toward the advancement of methadone treatment produce positive results.

This course fulfills the training requirement for certification as a Methadone Advocate. It is designed for non-clinicians, and involved eight hours of rigorous training. The course equips participants with the tools that they will need to succeed in the struggle to have methadone maintenance treatment universally accepted as the “gold standard” for addiction treatment.

With these goals in mind the course presentation is as follows:

  1. Addiction and Methadone – scientifically accurate yet in language understandable to the non-clinician.
  2. Regulations and Accreditation – explained by experts from CARF, COA and JCAHO who understand the systemic complexities.
  3. Faces of Advocacy – support for methadone treatment finds its source in both anticipated and unanticipated places in the community.
  4. The Certified Methadone Advocate (CMA) – the mechanism of certification and how it will professionalize those committed to advocacy.
  5. Methadone Stigma – a history of administrative and community prejudice directed at methadone patients, and analyses of possible solutions.

Candidates for certification must register with NAMA prior to the conference so that their Handbook may include information specific to their state.

Getting The Most From a Conference1
Jo. L. Sotheran, Ph.D.
National Alliance of Methadone Advocates

A short presentation on getting the most out of a conference, how to plan your time and networking skills. (powerpoint)

NAMA would like to thank Robert Kovacik— for donating his skills and materials to videotape the day’s training.

Photo Album of the CMA Training

Notes

1. This is a PowerPoint presentation.

Similar Posts

  • Statement About MMT from NIDDK

    Admin 04/25/2022

    From NIDDK Fact Sheet Chronic Hepatitis C: Current Disease Management “Strict abstinence from alcohol is recommended during therapy with interferon. Interferon therapy can be associated with relapse in people with a previous history of drug or alcohol abuse. Therefore, alpha interferon should be given with caution to a patient who has only recently stopped alcohol…

  • Stop Stigma Now

    Admin 10/06/2022

    Our Mission Today over a million people in this country are suffering from an addiction to opiates. The fortunate ones are those who have sought treatment… those who take a single dose of medication each day to be free of opiate addiction. It was 50 years ago that a group of three doctors at Rockefeller…

  • Drug Court Fact Sheet

    Admin 01/29/2022

    Methadone Maintenance and Other Pharmacotherapeutic Interventions in the Treatment of Opioid Dependence. Overview Drug Courts are being confronted with increasing numbers of opiate dependent offenders. This Fact Sheet is intended to dispel misperceptions and educate practitioners about the efficacy of medication assisted treatment. Opioid dependence is a devastating reality and a treatable disease. According to…

  • Expectations

    Admin 09/04/2021

    Every patient, in fact every member of the methadone community, has a right to expect that someone who represents themselves as a methadone advocate be knowledgeable in all aspects of methadone treatment. NAMA has created the Methadone Advocate Training and Methadone Advocate Certification for a whole host of reasons. Most of which we will discuss…

  • Policy Makers Luncheon

    Admin 11/11/2021

    National Methadone Conference AMTA 2001 Monday, October 8th, 11 am to 1 pm Chair Mark Parrino, American Methadone Treatment Association The Policy Maker’s Luncheon is an invitation only event that is attended by the federal and state agencies and national organizational representatives (i.e. ASAM, NAMA). Therefore no pictures were taken during the luncheon. The Policy…